Autor: Firma IMARC Group

Artificial Pancreas Device Systems Market

5. Januar 2021 Firma IMARC GroupForschung und Entwicklungbeta, bionics, cellnovo, cgm, diabetes, imarc, insulet, insulin, market, minimed, new, research, roche, smart, with

According to the IMARC Group, the global artificial pancreas device systems market to exhibit a CAGR of around 18% during 2020-2025. An artificial pancreas device system (APDS) refers to an autonomous system for glycemic control. It consists of a continuous glucose monitoring Mehr